Nu-Domperidone

Known as: Nu Domperidone, Nu Pharm Brand of Domperidone Maleate, Nu-Pharm Brand of Domperidone Maleate 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2017
012320002017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
  • Hikaru SuzuKIi, Yoshimichi YAMAMo'roi, H. SuzuKl
  • 2017
In small segments of circular smooth muscle iselated from the guinea-pig gastrie antrum, the effects of RHC-80267, an inhibitor… (More)
  • figure 2
Is this relevant?
2016
2016
237 Background: Pharmacist-provided patient education for oral chemotherapy is poorly documented in patient electronic medical… (More)
Is this relevant?
2009
2009
  • Spektrum der Augenheilkunde
  • 2009
Jetzt neu: Acular® Augentropfen, Wirkstoff: 0,5% Ketorolac-Trometamol Jedes Trauma am Auge, inbsbesondere aber das… (More)
Is this relevant?
2007
2007
  • 2007
<lb>76. Connor TH, Anderson RW, Sessink PJ et al. Effective-<lb>ness of a closed-system device in containing surface… (More)
  • table 1
Is this relevant?
2006
2006
Indomethacin has been suggested for the treatment of Alzheimer's disease (AD), but its use is limited by gastrointestinal and… (More)
Is this relevant?
2005
2005
heutigen Anschauung, zeigen, datl die spontane Entfieberung und die kfinstliche Antipyrese grundverschiedene Vorg~inge sind. Um… (More)
Is this relevant?
2005
2005
Post-transplant lymphoproliferative disorder (PTLD) is uncommonly of T-cell origin, especially following haematopoietic stem cell… (More)
  • figure 1
  • table 1
Is this relevant?
2005
2005
To develop an effective oral drug delivery system with accelerated absorption in human subjects for a poorly water-soluble… (More)
Is this relevant?
Review
2004
Review
2004
Vol. 37, No. 7, 1991 References 1. Podkowik BI, Repka ML, Smith ML. Interference by ritodrine in the GC/MS confirmation of delta… (More)
Is this relevant?
2004
2004
i. I. P. Anokhina, T. T. Bondarenko, G. D. Zabrodin et al., Zh. Nevropatol. Psikhiat., No. 2, 264 (1975). 2. V. I. Badikov… (More)
  • figure 2
  • figure 3
Is this relevant?